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myocardium should be considered in the diagnosis of CA. Cardiac
magnetic resonance imaging is valuable in the diagnosis of CA.
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OBJECTIVES Arrhythmogenic right ventricular dysplasia/cardiomyopa-
thy (ARVD/C) is an inherited cardiac disease associated with an increased
risk of arrhythmic sudden death. Mutations in desmosomal genes and
some extra-desmosomal genes have been identiﬁed to associate with
ARVD/C. Previously we identiﬁed 5 novel plakophilin (PKP2) mutations in
a cohort of Chinese patients with ARVD/C. Our present study is to deter-
mine the prevalence of other associated gene mutations in this ARVD/C
registry study and explore the potential genotype- phenotype relationship.
METHODS Genotypic and phenotypic proﬁles were studied in a cohort
of 32 symptomatic Han Chinese with a clinical or suspected diagnosis
of ARVD/C according to modiﬁed international Task Force criteria in
2010. Direct sequencing of 5 desmosomal genes and 3 extra-desmo-
somal genes was performed with a 3730XL DNA Analyzer.
RESULTS 22 mutations including 13 novel (13/22, 59.1%) in 5 desmo-
somal genes PKP2, Desmoplakin (DSP), Desmoglein-2 (DSG2), Des-
mocollin-2 (DSC2), Plakoglobin (JUP) were identiﬁed in 20 (20 of 32,
55.6%) patients in our cohort. No mutations were found in extra-
desmosomal genes. Among 32 patients, 11 (11 of 32, 34.4%) patients
have PKP2 mutations, 3 (9.4%) DSP, 3 (9.4%) DSG2, 6 (18.8%) DSC2
and 4 (12.5%) JUP. Multiple mutations were found in 6 subjects (6 of
32, 18.8%), among which 4 have PKP2 mutation, 3 DSC2, 3 DSP and 3
JUP. Genotype-phenotype analysis indicates compound multiple
mutations may predict major structural abnormalities.
CONCLUSIONS PKP2 mutation is the most common gene mutations
in our ARVD/C cohort. A higher percentage of DSC2 and JUP mutations
were identiﬁed in the cohort compared with previous reports. Com-
pound multiple mutations are common and may indicate major
structural abnormalities. Extra-desmosomal genes mutations are rare
in our Chinese ARVD/C cohort.
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OBJECTIVES Contrast echocardiography with left ventricular opaci-
ﬁcation (LVO) can improve endocardium deﬁnition and potentially
becomes supplement of conventional two-dimensional echo (2DE) in
the diagnosis of noncompaction of the ventricular myocardium
(NCVM). This study aimed to access the feasibility, accuracy, repro-
ducibility of LVO & its incremental value than 2DE in NCVM diagnosis.
METHODS LVO & 2DE were performed in 85 patients (54 men, mean
age 4020 years) with suspected NCVM (NCVM Gp), and 2DE were
performed in 40 healthy volunteers (Normal Gp, 20 men, mean age 40
 23 years). The LV chamber size and LV ejection fraction derived
from Biplane Simpson’s formula were compared among LVO-NCVM
Gp, 2DE-NCVM Group & 2DE-Normal Gp. The location and extent of
NCVM were evaluated based on AHA/ACA 16 segment model for LV
segmentation, and the thickness ratio of noncompacted to compacted
myocardium (NCR) were assessed on LVO & 2DE by 2 independently
blinded experienced echo-cardiologists.
RESULTS (1) Compared with the Normal Gp, the NCVM Gp showed
larger LVEDD (58.911.6mm vs. 455.1mm), LVEDV (12111.5ml vs.
9514.8), LVESD (43.03.44mm vs. 334.0mm), LVESV (74.33.94ml
vs. 444.4ml), lower LVEF (40.813.2% vs. 65.67.1%) and E/A ratio
(0.820.32 vs. 1.620.5) using 2DE method (p<0.05).
(2) Within the NCVM Gp, compared with the values from 2DE
method, LVEDD (65.27.8mm vs. 58.911.6mm), LVEDV (16214.8mlvs. 12111.5ml), LVESD (47.85.67mm vs. 43.03.44mm), LVESV
(84.72.46ml vs. 74.33.94ml) derived from LVO method were larger
and LVEF (38.212.4 vs. 40.813.2) on LVO was slightly lower (p<0.05).
(3) Among the whole 1360 LV segments in NCVM Gp, there were
more segments adequately visualized for analysis on LVO than on 2DE
(1278 vs. 1183, 93.97% vs. 86.99%). There were more noncompaction
segments detected on LVO than on 2DE (314 vs. 262, 23.09% vs.
19.26%). Of the 921 segments interpreted as normal on 2DE, 52 seg-
ments (5.65%) were noncompacted on LVO. NCVM on LVO were
majorly located in medium (53.18%), apical (46.18%) segments and
lateral wall (39.81%); rarely involved in basal segment (0.64%).
(4) NCR on LVO was greater than that on 2DE (4.21.3 vs. 3.31.2,
P<0.0001), but they are highly related and both showed excellent
interobserver consistency. The coefﬁcient of inter-observer variability
of NCR was slightly smaller using LVO than 2DE (5.2% vs. 6.6%).
(5) The NCVM detection rate using 2DE, LVO, 2DEþLVO were sta-
tistically different, with the highest detection rate on 2DEþLVO and
lowest detection rate on 2DE (89.4% vs. 63.5%, p<0.05).
CONCLUSIONS Contrast echo can clinically improve the diagnosis of
NCVM in accuracy, sensitivity & reproducibility, and act as a useful
supplement to the routine two-dimensional transthoracic echo.
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OBJECTIVES Hypertrophic cardiomyopathy (HCM) is the most com-
mon genetic cardiovascular disorder.This genetic diversity modiﬁer
genes form the basis of its phenotypic heterogeneity.
METHODS Clinical, three-dimensional speckle tracking (3D-STI),
electrocardiographic (ECG), cardiac magnetic resonance (CMR) and
echocardiographic(UCG) examination in members of a three-genera-
tion Chinese family was followed by exon and boarding intron anal-
ysis of 96 genes in the proband using second-generation sequencing.
The identiﬁed mutations were conﬁrmed by bi-directional Sanger
sequencing in all family members and 300 healthy controls.
RESULTS The deleted mutation 3624 del C in exon 31 of the MYBPC3
gene were identiﬁed in proband and two family members(subjects I-2,
III-1).While the remaining family and 300 normal controls did not ﬁnd
this mutation. The onset ageproband is 42 years old and subject I-2 is
50 years old. Both of them were accompanied by chest pain. Subject
III-1 UCG and CMR were normal. However his ECG showed sinus
bradycardia and paroxysmal supraventriculararrhythmias. CMR re-
sults showed that proband has myocardial ﬁbrosis in base-septal and
anterior wall of left ventricular. Subjects I-2 has myocardial ﬁbrosis in
middle-septal, anterior wall and inferior wall of left ventricular.
Themutation carriers showed septal, anterior wall, inferior wall and
apical of left ventricular hypertrophy in UCG compared with the no-
mutation carriers, in the family; In 3D-STI, the global and the
segmental longitudinal strain in middleof the posterior interventric-
ular septum, the base and the middle of anterior interventricular
septum, and the middle of the left ventricular anterior wall were
reduced. Furthmore the segmental area strain in the base of the
anteriorinterventricular septum were reduced (P <0.05).
CONCLUSIONS We demonstrate a close correlation between clinical
phenotype and genotype of MYBPC3 gene Pro1208fs mutation in a
Chinese family with HCM for the ﬁrst time. The mutation results in
100% penetrance. Mutation carriers arelate age of onset and no spe-
ciﬁc clinical symptoms. Partial myocardial ﬁbrosis and Maron III type
hypertrophy and a high potential of abnormal myocaidial systolic
function were detected suggesting the pathogenesis of themutation.
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OBJECTIVES Dilated cardiomyopathy (DCM) is characterized by left
ventricular enlargement, systolic dysfunction, and heart failure. Both ge-
netic and non-genetic factors have been linked to DCM pathogenesis.
Familial DCM (FDCM) accounts for 20%-50% of all DCM cases, highlighting
the importance of genetic in pathogenesis. Indeed, more than 40 DCM
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diac troponin T type-2 (TNNT2). We examined polymorphisms of the
TNNT2 gene in a Kazak family from Xinjiang, China, and in idiopathic
DCM (IDCM) patients of both Kazak and Han ethnicity.
METHODS Peripheral blood samples were collected from 9 members
of the FDCM, from 180 patients with IDCM (90 Kazak and 90 Han), and
180 healthy controls (90 Kazak and 90 Han). PCR was used to amplify
15 exons and nearby introns of the TNNT2 gene. The ampliﬁed prod-
ucts were sequenced and compared to the standard sequence in
Pubmed by BLAST and CHROMAS software, to identify mutation sites.
RESULTS IDCM from Kazak and Han were complied for Hardy-Weinberg
equilibrium. There was a signiﬁcant difference in the genotype distribu-
tion (c2 ¼6.67, P ¼0.015) and allele frequency (c2 ¼5.17, P ¼0.0017) be-
tween Kazaks with IDCM and Kazak controls of SNP rs3729547.
Meanwhile, it also has a difference in the genotype distribution (c2 ¼7.62,
P ¼0.022) and allele frequency (c2 ¼6.73, P ¼0.009) between Han with
IDCM and Han controls, but the rate of IDCM was descend. A novel
variant (c.617G > T) was identiﬁed in one FDCM patient at exon 13, this
mutation caused an amino acid substitution.
CONCLUSIONS The TNNT2 SNP rs3729547 is not only a possible in-
dependent risk factor for Han ethnicity, but also for Kazak ethnicity.
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OBJECTIVES To investigate the immediate and short-term thera-
peutic efﬁcacy and feasibility of coil embolization of a targeted septal
artery in patients with hypertrophic obstructive cardiomyopathy
(HOCM).
METHODS Four patients with hypertrophic obstructive cardiomyop-
athy refractory to medication were chosen, and treated with coil
embolization of a targeted septal artery. Preoperative, intraoperative
and postoperative left ventricular outﬂow tract pressure gradient
(LVOTPG), septal thickness and systolic anterior motion of mitral
(SAM) phenomenon were compared. Postoperative complications and
improvement of clinical symptoms were observed.
RESULTS Embolization of the targeted septal branch was successfully
performed in 4 patients. Compared with preoperative LVOTPG of
patients after balloon pressure and complete occlusion were signiﬁ-
cantly lower(92.5026.30 vs. 38.006.93 and 28.256.24 mmHg;
P <0.05, respectively). The average septal thickness of patients at one
month after operation was not statistically signiﬁcant difference
compared with the preoperative value(18.402.36 vs. 18.682.42 mm;
P >0.05, respectively). Follow-up of the 4 cases at 1 month after
operation revealed remarkable attenuation of SAM phenomenon. We
did not detect ventricular tachycardia and atrioventricular block.
Postoperative NYHA classiﬁcation were signiﬁcantly lower than
baseline (3.000.82 vs. 1.500.58; P <0.05, respectively).
CONCLUSIONS The study showed treatment for hypertrophic obstruc-
tive cardiomyopathy by coil embolization of a targeted septal artery is
feasible.In the treatment of HOCM, coil embolization of a targeted septal
artery can signiﬁcantly reduce LVOTPG and improve clinical symptoms.
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OBJECTIVES Recent studies have shown that smoking and drinking
are associated with poorer outcomes in patients with cardiomyopa-
thy. The purpose of this study was to determine all-cause mortality in
dilated cardiomyopathy (DCM) associated with smoking and drinking.METHODS An observational cohort study was undertaken in DCM pa-
tients from November 2003 to September 2011. A total of 1118 patients
were enrolled, with a mean follow-up of 3.52.3 years. Standard de-
mographics were obtained, and transthoracic echocardiography and
routine blood testing were performed shortly after admission. Outcome
assessment was based on the all-cause death after admission.
RESULTS The patients were divided into three groups: non-smokers
(n ¼593), mild to moderate smokers (n ¼159) and heavy smokers
(n ¼366). The all-cause mortality rates showed no differences between
the three groups (23.8%, 20.8% and 24%, respectively; log-rank c2 ¼1.281,
P ¼0.527). There was also no signiﬁcant difference in mortality between
non-drinkers (n ¼747), mild drinkers (n ¼142) and moderate drinkers
(n ¼229) (23.7%, 23.2% and 22.3%, respectively; log-rank c2 ¼2.343,
P ¼0.310). In the Cox analysis, neither the smoking (HR 0.971, P ¼0.663)
nor the drinking status (HR 0.891, P ¼0.140) was a signiﬁcant indepen-
dent predictor of all-cause mortality in patients with DCM.
CONCLUSIONS In conclusion, there were no signiﬁcant differences in
mortality between the smoking- and drinking-related patient groups,
indicating no effect of smoking and drinking on all-cause mortality in
patients with DCM in the present large-scale study.
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OBJECTIVES The growing number of heart failure patients is becoming
an important issue in cardiology. B-natriuretic peptide (BNP) is a recog-
nized marker of heart failure, including in patients with dilated cardio-
myopathy. The Tei index is an indicator of left ventricular function. The
aim of the study was to evaluate the relationship between Tei index and
the concentration of plasma BNP in dilated cardiomyopathy patients.
METHODS Fifty patients with dilated cardiomyopathy were enrolled
in the study. Fifty healthy individuals were assigned to the control
group. BNP was measured by enzyme linked immunosorbent assay
(ELISA). Echocardiography was performed to calculate Tei index.
RESULTS Median value of BNP in patients with dilated cardiomyop-
athy was 1086.1 pg/ml, and 42.8 pg/ml in control group (p < 0.05). The
median value of the Tei index was 0.80 in patients with dilated car-
diomyopathy, 0.30 in individuals with control group. LVEDD, LVESD
were signiﬁcantly higher in dilated cardiomyopathy patients also. All
the differences were statistically signiﬁcant (p < 0.05). A signiﬁcant
positive correlation (R¼0.401, p < 0.05) between BNP and the TEI
index was found. The stepwise regression analysis showed closer
relationship existing in Tei index and BNP.
CONCLUSIONS Tei index, BNP was signiﬁcantly increased in dilated
cardiomyopathy patients. There was a signiﬁcant positive correlation
between them. Tei index was a better index to estimate ventricular
global function than other conventional indices.
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OBJECTIVES To evaluate the feasibility and the safety after non-
surgical septal myocardial reduction by coil embolization in hyper-
trophic obstructive cardiomyopathy (HOCM).
METHODS Thirteen patients (pts) (male: 5 pts; mean age: 48 (10 years)
with HOCM and drug-refractory symptoms underwent ablation of
septal hypertrophy by coil embolization with detachable coils. The
Tornado coils (Cook Inc, Bloomington, IN, USA), 3 or 4mm in diam-
eter and 2 or 3cm in length, were delivered through a 3F RenegadeTM
Hi-Flo microcatheter (Boston Scientiﬁc Scimed, Maple Grove, MN,
USA) positioned inside the target vessel as distally as possible. One or
more straight coils were used for each target vessel until complete
ﬂow obstruction was noted. The intraventricular pressure gradient
